UBS AM
DBD

UBS AM’s Diebold Nixdorf Incorporated DBD Stock Holding History

UBS AM’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,035
Closed -$173K – 2780
2022
Q3 		$173K Sell
71,035
-15,372
-18% -$51.3K ﹤0.01% 2630
2022
Q2 		$196K Hold
86,407
– – ﹤0.01% 2582
2022
Q1 		$582K Hold
86,407
– – ﹤0.01% 2410
2021
Q4 		$782K Hold
86,407
– – ﹤0.01% 2345
2021
Q3 		$874K Sell
86,407
-8,816
-9% -$96.7K ﹤0.01% 2239
2021
Q2 		$1.22M Buy
95,223
+5,001
+6% +$68.6K ﹤0.01% 2104
2021
Q1 		$1.27M Sell
90,222
-297
-0.3% -$4.09K ﹤0.01% 1968
2020
Q4 		$965K Buy
90,519
+27,434
+43% +$249K ﹤0.01% 2013
2020
Q3 		$482K Sell
63,085
-1,374
-2% -$10.1K ﹤0.01% 2162
2020
Q2 		$391K Sell
64,459
-5,120
-7% -$25.3K ﹤0.01% 2210
2020
Q1 		$245K Sell
69,579
-6,987
-9% -$59.2K ﹤0.01% 2215
2019
Q4 		$809K Sell
76,566
-14,609
-16% -$130K ﹤0.01% 2026
2019
Q3 		$1.02M Sell
91,175
-19,255
-17% -$228K ﹤0.01% 1940
2019
Q2 		$1.01M Buy
110,430
+7,559
+7% +$78.9K ﹤0.01% 1879
2019
Q1 		$1.14M Buy
102,871
+47,124
+85% +$329K ﹤0.01% 1773
2018
Q4 		$139K Buy
55,747
+3,484
+7% +$12.5K ﹤0.01% 2476
2018
Q3 		$235K Hold
52,263
– – ﹤0.01% 2371
2018
Q2 		$625K Sell
52,263
-12,363
-19% -$165K ﹤0.01% 2000
2018
Q1 		$995K Buy
64,626
+12,184
+23% +$203K ﹤0.01% 1784
2017
Q4 		$857K Buy
52,442
+898
+2% +$17.4K ﹤0.01% 1807
2017
Q3 		$1.18M Buy
51,544
+388
+0.8% +$8.27K ﹤0.01% 1637
2017
Q2 		$1.43M Sell
51,156
-3,910
-7% -$108K ﹤0.01% 1500
2017
Q1 		$1.69M Buy
55,066
+6,077
+12% +$172K ﹤0.01% 1415
2016
Q4 		$1.23M Sell
48,989
-9,547
-16% -$225K ﹤0.01% 1475
2016
Q3 		$1.45M Buy
58,536
+1,936
+3% +$51.4K ﹤0.01% 1505
2016
Q2 		$1.41M Buy
56,600
+5,529
+11% +$142K ﹤0.01% 1499
2016
Q1 		$1.48M Buy
51,071
+281
+0.6% +$7.34K ﹤0.01% 1472
2015
Q4 		$1.53M Sell
50,790
-48
-0.1% -$1.63K ﹤0.01% 1563
2015
Q3 		$1.51M Buy
50,838
+12,940
+34% +$421K ﹤0.01% 1554
2015
Q2 		$1.33M Sell
37,898
-1,867
-5% -$65.9K ﹤0.01% 1577
2015
Q1 		$1.41M Buy
39,765
+1,100
+3% +$37.1K ﹤0.01% 1500
2014
Q4 		$1.34M Buy
38,665
+2,100
+6% +$74.1K ﹤0.01% 1491
2014
Q3 		$1.29M Buy
36,565
+1,400
+4% +$52.8K ﹤0.01% 1468
2014
Q2 		$1.41M Sell
35,165
-100
-0.3% -$3.84K ﹤0.01% 1463
2014
Q1 		$1.41M Buy
35,265
+1,000
+3% +$36K ﹤0.01% 1449
2013
Q4 		$1.13M Sell
34,265
-2,400
-7% -$74.8K ﹤0.01% 1470
2013
Q3 		$1.08M Hold
36,665
– – ﹤0.01% 1475
2013
Q2 		$1.24M Buy
+36,665
New +$1.13M ﹤0.01% 1367

Other funds holding DBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS AM's DBD Position: Q4 2022 in Review

UBS AM sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 71,035 shares — an estimated $173K sold.

UBS AM first reported a position in DBD in Q2 2013 and held it in 38 quarters. The position peaked at $1.69M in Q1 2017. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • UBS AM reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • UBS AM sold 71,035 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $173K.
  • UBS AM first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 38 quarters.
  • UBS AM's Diebold Nixdorf Incorporated position peaked at $1.69M in Q1 2017.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.